Jane Street’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$764K Sell
11,900
-46,300
-80% -$4.22M ﹤0.01% 7083
2025
Q4
$7.57M Sell
58,200
-63,000
-52% -$8.65M ﹤0.01% 2672
2025
Q3
$13.1M Sell
121,200
-315,900
-72% -$34.4M ﹤0.01% 2087
2025
Q2
$40.3M Buy
437,100
+413,200
+1,729% +$32.4M 0.01% 906
2025
Q1
$2.12M Buy
+23,900
New +$2.07M ﹤0.01% 4259
2022
Q2
Sell
-4,924
Closed -$499K 11035
2022
Q1
$499K Buy
4,924
+4,251
+632% +$473K ﹤0.01% 7492
2021
Q4
$99K Buy
673
+34
+5% +$7.6K ﹤0.01% 9261
2021
Q3
$160K Buy
639
+312
+95% +$107K ﹤0.01% 9019
2021
Q2
$151K Buy
+327
New +$140K ﹤0.01% 9043

Other funds holding WGS

Jane Street's WGS Position: Q1 2026 in Review

Jane Street sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 29,625 shares — an estimated $2.7M sold.

Jane Street first reported a position in WGS in Q2 2021 and held it in 15 quarters. The position peaked at $9.94M in Q3 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Jane Street reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 29,625 GeneDx Holdings shares in Q1 2026, an estimated $2.7M.
  • Jane Street first reported a position in GeneDx Holdings in Q2 2021 and held it in 15 quarters.
  • Jane Street's GeneDx Holdings position peaked at $9.94M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.